TRACON Pharmaceuticals (TCON) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free TCON Stock Alerts $1.62 -0.35 (-17.77%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media TRACON Pharmaceuticals Short Interest DataCurrent Short Volume153,000 sharesPrevious Short Volume24,400 sharesChange Vs. Previous Month+527.05%Dollar Volume Sold Short$264,690.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares2,280,000 sharesFloat Size2,100,000 sharesShort Percent of Float7.29%Today's Trading Volume201,953 sharesAverage Trading Volume194,335 sharesToday's Volume Vs. Average104% Short Selling TRACON Pharmaceuticals ? Sign up to receive the latest short interest report for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTCON Short Interest Over TimeTCON Days to Cover Over TimeTCON Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. TRACON Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024153,000 shares $264,690.00 +527.1%7.3%0.6 $1.73 4/15/202424,400 shares $43,920.00 -96.7%1.2%0.1 $1.80 3/31/2024744,900 shares $6.40 million -60.8%N/A0.2 $8.60 3/15/20241,900,000 shares $712,500.00 +323.5%N/A0.7 $0.38 2/29/2024448,700 shares $81,214.70 -47.6%N/A0.2 $0.18 2/15/2024856,300 shares $162,868.26 -29.8%N/A0.5 $0.19 Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,220,000 shares $235,948.00 +43.0%N/A0.2 $0.19 1/15/2024853,100 shares $144,344.52 -52.3%N/A0.2 $0.17 12/31/20231,790,000 shares $313,429.00 +178.9%N/A0.4 $0.18 12/15/2023641,900 shares $120,035.30 -74.2%N/A0.1 $0.19 11/30/20232,490,000 shares $509,205.00 +23.9%N/A0.6 $0.20 11/15/20232,010,000 shares $340,092.00 +53.4%N/A0.5 $0.17 10/31/20231,310,000 shares $227,547.00 +265.8%N/A1.6 $0.17 10/15/2023358,100 shares $68,755.20 +0.8%N/A0.4 $0.19 9/30/2023355,200 shares $63,225.60 -27.5%N/A0.6 $0.18 9/15/2023489,600 shares $124,358.40 +21.0%N/A0.9 $0.25 8/31/2023404,700 shares $106,840.80 +70.1%N/A0.9 $0.26 8/15/2023237,900 shares $63,995.10 -31.8%N/A0.5 $0.27 7/31/2023348,700 shares $104,923.83 +37.9%N/A1 $0.30 7/15/2023252,800 shares $75,713.60 +78.5%N/A0.8 $0.30 6/30/2023141,600 shares $41,205.60 -37.2%N/A0.5 $0.29 6/15/2023225,300 shares $114,474.93 +38.0%N/A1 $0.51 5/31/2023163,300 shares $94,224.10 +1.4%N/A0.9 $0.58 5/15/2023161,000 shares $104,682.20 -38.7%N/A0.9 $0.65 4/30/2023262,500 shares $207,112.50 +100.7%N/A1.5 $0.79 4/15/2023130,800 shares $253,752.00 +5.7%N/A0.9 $1.94 3/31/2023123,700 shares $233,793.00 +4.1%N/A1.5 $1.89 3/15/2023118,800 shares $180,576.00 -16.7%N/A1.4 $1.52 2/28/2023142,600 shares $219,604.00 -11.1%N/A0.9 $1.54 2/15/2023160,400 shares $267,868.00 -24.6%N/A1.1 $1.67 1/31/2023212,700 shares $357,336.00 -24.6%N/A1.3 $1.68 1/15/2023282,000 shares $502,834.20 -21.3%N/A1.8 $1.78 12/30/2022358,200 shares $533,718.00 +48.8%N/A2.3 $1.49 12/15/2022240,800 shares $308,224.00 +66.9%N/A1.6 $1.28 11/30/2022144,300 shares $217,171.50 -2.8%N/A2 $1.51 11/15/2022148,500 shares $227,205.00 -1.5%N/A2.1 $1.53 10/31/2022150,700 shares $238,106.00 +23.6%N/A2.1 $1.58 10/15/2022121,900 shares $201,135.00 -5.9%N/A1.9 $1.65 9/30/2022129,500 shares $216,265.00 -7.2%N/A2.1 $1.67 9/15/2022139,600 shares $262,448.00 +6.8%N/A2.2 $1.88Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. TCON Short Interest - Frequently Asked Questions What is TRACON Pharmaceuticals' current short interest? Short interest is the volume of TRACON Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 153,000 shares of TCON short. 7.29% of TRACON Pharmaceuticals' shares are currently sold short. Learn More on TRACON Pharmaceuticals' current short interest. What is a good short interest ratio for TRACON Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCON shares currently have a short interest ratio of 1.0. Learn More on TRACON Pharmaceuticals's short interest ratio. What is a good short interest percentage for TRACON Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.29% of TRACON Pharmaceuticals' floating shares are currently sold short. Is TRACON Pharmaceuticals' short interest increasing or decreasing? TRACON Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 153,000 shares, an increase of 527.0% from the previous total of 24,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TRACON Pharmaceuticals' float size? TRACON Pharmaceuticals currently has issued a total of 2,280,000 shares. Some of TRACON Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRACON Pharmaceuticals currently has a public float of 2,100,000 shares. How does TRACON Pharmaceuticals' short interest compare to its competitors? 7.29% of TRACON Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TRACON Pharmaceuticals: TC Biopharm (Holdings) Plc (5.87%), Fresh Tracks Therapeutics, Inc. (0.17%), Finch Therapeutics Group, Inc. (4.88%), Palisade Bio, Inc. (21.34%), Titan Pharmaceuticals, Inc. (1.99%), Avalon GloboCare Corp. (1.02%), Creative Medical Technology Holdings, Inc. (1.55%), Windtree Therapeutics, Inc. (2.99%), Organovo Holdings, Inc. (4.09%), BioCardia, Inc. (0.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short TRACON Pharmaceuticals stock? Short selling TCON is an investing strategy that aims to generate trading profit from TRACON Pharmaceuticals as its price is falling. TCON shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TRACON Pharmaceuticals? A short squeeze for TRACON Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCON, which in turn drives the price of the stock up even further. How often is TRACON Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCON, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TCBP Short Interest FRTX Short Interest FNCH Short Interest PALI Short Interest TTNP Short Interest ALBT Short Interest CELZ Short Interest WINT Short Interest ONVO Short Interest BCDA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCON) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts